Patents by Inventor John Deaton

John Deaton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240325465
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: June 6, 2024
    Publication date: October 3, 2024
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Patent number: 12005087
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: June 11, 2024
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20240075078
    Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Application
    Filed: November 14, 2023
    Publication date: March 7, 2024
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Patent number: 11813296
    Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: November 14, 2023
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20230116978
    Abstract: This disclosure relates to an enzymatic method including the steps of adding water to a reactor vessel with gentle mixing and minimal heating, adding osmotic protectant solution, adding plant material to the reactor, adding cell wall degrading enzymes at 0.1% wt/wt based on plant weight, heating the reactor now filled with plant material, osmotic protectant solution and enzyme blend solution to 30° C.-35° C., adding the enzyme mixture to the reactor and starting the timer for up to 2 hours, adding bulk density enhancer, further mixing the product, and drying the finished product containing protoplasts. The protoplast containing product may be provided in a dietary supplement for human use having antioxidant and anti-inflammatory properties.
    Type: Application
    Filed: October 14, 2022
    Publication date: April 20, 2023
    Applicant: Deerland Enzymes, Inc.
    Inventor: John Deaton
  • Publication number: 20230022942
    Abstract: The disclosure relates to a method for a non-invasive technique to analyze the fate of probiotics and commensal microbiota from the human upper gastrointestinal tract, namely the ileum. The invention further relates to methods for the enumeration and determination of mechanism of action of probiotics in a non-invasive manner from the end of the small intestine. A composition comprising a probiotic delivered in vivo to healthy individuals with an ileostomy bag is described.
    Type: Application
    Filed: July 25, 2022
    Publication date: January 26, 2023
    Inventors: Martin Joseph Mary Buckley, Daniela Alexandra da Silva Freitas, Andre Brodkorb, John Deaton
  • Publication number: 20210401008
    Abstract: Provided herein are compositions and processes for producing compositions from an algae to provide heme and a red or red-like color to edible compositions including ingredients and finished food products. Also provided are methods of growing heme-producing algae, methods of producing algae preparations therefrom and methods of making ingredients and food products with algae preparations. Also provided are compositions, including edible compositions that include heme and other nutrient components produced from algae.
    Type: Application
    Filed: November 7, 2019
    Publication date: December 30, 2021
    Inventors: Miller Tran, John Deaton, Brock Adams, Michael Mayfield, Amanda Longo, Oscar Gonzalez, Jon Hansen, Xun Wang, David Schroeder
  • Publication number: 20210386088
    Abstract: Provided herein are compositions and processes for producing compositions from an algae that overproduces protoporphyrin IX (PPIX). Also provided are methods of growing PPIX overproducing algae, methods of isolating PPIX-containing portions from algae cultures and compositions and methods of making food products with PPIX produced by algae. Provided herein are strains and methods to select strains that overproduce PPIX. Also provided are compositions, including edible compositions that include PPIX produced from algae. Specifically, the algal strain over-producing PPIX is an engineered strain of The algal biomass may be used for preparing meat analogues wherein the PPIX compound imparts a meat-like colour and flavour.
    Type: Application
    Filed: November 7, 2019
    Publication date: December 16, 2021
    Inventors: Miller Tran, John Deaton, Brock Adams, Michael Mayfield, Amanda Longo, Oscar Gonzalez, Jon Hansen, Xun Wang, David Schroeder
  • Patent number: 11160838
    Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.
    Type: Grant
    Filed: August 10, 2020
    Date of Patent: November 2, 2021
    Assignee: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210315808
    Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.
    Type: Application
    Filed: June 21, 2021
    Publication date: October 14, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210315945
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: June 22, 2021
    Publication date: October 14, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20210145899
    Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.
    Type: Application
    Filed: August 10, 2020
    Publication date: May 20, 2021
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20200370004
    Abstract: The present disclosure provides for growing algae with an exogenous organic carbon source as the primary carbon source, in light, dark or limited light conditions. Also provided are expression cassettes for expression of a recombinant protein in an algae species grown in dark or limited light conditions.
    Type: Application
    Filed: November 13, 2018
    Publication date: November 26, 2020
    Inventors: Miller Tran, Jon Hansen, John Deaton, Xun Wang, Oscar Gonzalez, Michael Mayfield, Stephen Mayfield
  • Publication number: 20200332249
    Abstract: Provided herein are recombinant microalgae containing one or more polynucleotides encoding iron-complexed proteins, methods of producing the iron-complexed proteins with the microalgae, and edible products formed therefrom.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 22, 2020
    Inventors: Miller Tran, Brock Adams, John Deaton, Oscar Gonzalez, Jon Hansen, Amanda Longo, Michael Mayfield, Xun Wang
  • Publication number: 20200108106
    Abstract: Methods of using Bacillus Subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus Subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190255122
    Abstract: This disclosure provides a method of treating gastrointestinal inflammation such as inflammatory bowel disease (IBS) with a bacteriophage containing composition. The bacteriophage containing composition can be used as prebiotic supplementation and support of the gastrointestinal microflora. This disclosure relates to compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.
    Type: Application
    Filed: September 25, 2018
    Publication date: August 22, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190125811
    Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.
    Type: Application
    Filed: September 25, 2018
    Publication date: May 2, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20190125810
    Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.
    Type: Application
    Filed: September 25, 2018
    Publication date: May 2, 2019
    Applicant: Deerland Enzymes, Inc.
    Inventors: John Deaton, Ana Maria Cuentas
  • Publication number: 20180161382
    Abstract: Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.
    Type: Application
    Filed: December 11, 2017
    Publication date: June 14, 2018
    Inventors: John Deaton, Elizabeth Ertle, Hilton Grant Dawson
  • Patent number: 9839657
    Abstract: Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 12, 2017
    Assignee: DEERLAND ENZYMES, INC.
    Inventors: John Deaton, Elizabeth Ertle, Hilton Grant Dawson